Search

Search Results

• TYROSINE KINASE INHIBITORS AND PREGNANCY

  Elisabetta Abruzzese, Malgorzata Monika Trawinska, Paolo De Fabritiis, Alessio Pio Perrotti

  e2014028

  2014-04-07

  https://doi.org/10.4084/mjhid.2014.028

  3638

  PDF: 1660

  HTML: 2679

• Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia

  Massimo Breccia, Gioia Colafigli, Luisa Quattrocchi, elisabetta abruzzese, giuliana alimena

  e2016016

  2016-02-20

  https://doi.org/10.4084/mjhid.2016.016

  2931

  PDF: 697

  HTML: 1938

  figure 1: 176

  figure 2: 183

• Successful management of pregnancy and hepatic toxicity in a CML female patient treated with nilotinib : a case report and a review

  Domenico Santorsola, Elisabetta Abruzzese

  e2015020

  2015-02-12

  https://doi.org/10.4084/mjhid.2015.020

  2031

  PDF: 1228

  HTML: 1635

• Primary pulmonary Hodgkin Lymphoma simulating a mediastinal tumour: an uncommon occurrence.

  Stefano Fratoni, Pasquale Niscola, Elisabetta Abruzzese, Malgorzata Monika Trawinska, Edoardo Mercadante, Andrea Casullo, Paolo de Fabritiis, Alessio Perrotti, Giuseppe Santeusanio

  e2013013

  2013-02-16

  https://doi.org/10.4084/mjhid.2013.013

  1348

  PDF: 715

  HTML: 1966

• PROGNOSTIC SIGNIFICANCE OF TRANSCRIPT-TYPE BCR/ABL1 IN CHRONIC MYELOID LEUKEMIA

  matteo molica, elisabetta abruzzese, massimo breccia

  e2020062

  2020-09-12

  https://doi.org/10.4084/mjhid.2020.062

  3829

  PDF: 1613

  HTML: 657

• Epidemiological surveillance of SARSCov2 in β-Thalassemia Patients in the last two years: reinfection rate, insights and future challenges

  Lorenza Torti, Francesco Sorrentino, Laura Maffei, Paolo De Fabritiis, Elisabetta Abruzzese

  e2023007

  2023-01-01

  https://doi.org/10.4084/MJHID.2023.007

  1147

  PDF: 937

  HTML: 418

• NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms

  Gianfranco Catalano, Pasquale Niscola, Cristina Banella, Daniela Diverio, Malgorzata Monika Trawinska , Stefano Fratoni, Rita Iazzoni, Paolo de Fabritiis, Elisabetta abruzzese, Nelida Ines Noguera

  e2020083

  2020-10-27

  https://doi.org/10.4084/mjhid.2020.083

  1726

  PDF: 1200

  HTML: 234

• TREATMENT PATTERNS IN PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKAEMIA IN ROUTINE CLINICAL PRACTICE: THE SIMPLICITY ITALIAN POPULATION

  Elisabetta Abruzzese

  e2019025

  2019-04-26

  https://doi.org/10.4084/mjhid.2019.025

  2011

  PDF: 1082

  HTML: 178

• Impact of SARS CoV-2 in hemoglobinopathies: a protective mechanism being from Beta chain Hemoglobin defects? SARS-CoV-2 and Hemoglobinopathies

  Lorenza Torti, Laura Maffei, Francesco Sorrentino, Paolo De Fabritiis, Rossella Miceli, Elisabetta Abruzzese

  e2020052

  2020-06-28

  https://doi.org/10.4084/mjhid.2020.052

  1622

  PDF: 943

  HTML: 412

• Obituary of Prof. Michele Baccarani

  Elisabetta Abruzzese

  e2022015

  2022-01-01

  https://doi.org/10.4084/MJHID.2022.015

  992

  PDF: 487

  HTML: 198

• Acquired CD20 Loss as a Mechanism of Resistance to Mosunetuzumab in Relapsed Follicular Lymphoma

  Martina Canichella, Stefano Fratoni, Carla Mazzone, alice di rocco, elisabetta abruzzese

  e2026014

  2026-01-01

  https://doi.org/10.4084/MJHID.2026.014

  821

  PDF: 723

  Html: 141

• SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19

  Elisabetta Abruzzese, Luigia Luciano, Francesco D'Agostino, Malgorzata Monika Trawinska, Fabrizio Pane, Paolo de Fabritiis

  e2020031

  2020-04-27

  https://doi.org/10.4084/mjhid.2020.031

  3294

  PDF: 1556

  HTML: 450